Similar Papers

Paper Title
Journal
Date
Author
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
Mitsukuni Suenaga ... Marta Schirripa
International journal of cancer | VOL. 144
Mitsukuni Suenaga, et. al.Mitsukuni Suenaga ... Marta Schirripa
14 Dec 2018
Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis
Dedong Cao ... Huilin Xu
Scientific Reports | VOL. 9
Dedong Cao, et. al.Dedong Cao ... Huilin Xu
01 Dec 2019
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.
Shubhadeep D Sinha ... Ghanashyam Biswas
Cancer Informatics | VOL. 22
Shubhadeep D Sinha, et. al.Shubhadeep D Sinha ... Ghanashyam Biswas
01 Jan 2023
Value of bevacizumab in treatment of colorectal cancer: A meta-analysis
Chun-Ying Qu
World Journal of Gastroenterology | VOL. 21
Chun-Ying QuChun-Ying Qu
01 Jan 2015
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Comments on The Study of Correlation Between Progression-Free and Overall Survival in Patients with Hodgkin Lymphoma
Yue-Can Zeng ... Yi Wang
Annals of Oncology | VOL. -
Yue-Can Zeng, et. al.Yue-Can Zeng ... Yi Wang
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.